Royalty Pharma
RPRX
#1213
Rank
โ‚น1.266 T
Marketcap
โ‚น2,149
Share price
-0.08%
Change (1 day)
-5.14%
Change (1 year)

Revenue for Royalty Pharma (RPRX)

Revenue in 2024 (TTM): โ‚น189.04 Billion

According to Royalty Pharma's latest financial reports the company's current revenue (TTM ) is โ‚น193.01 Billion. In 2023 the company made a revenue of โ‚น196.01 Billion an increase over the revenue in the year 2022 that were of โ‚น185.12 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Royalty Pharma from 2019 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น189.04 B-3.56%
2023 โ‚น196.01 B5.88%
2022 โ‚น185.12 B8.64%
2021 โ‚น170.40 B9.79%
2020 โ‚น155.21 B19.97%
2019 โ‚น129.37 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น47.31 B-75.49%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.510 T 1,718.93%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.480 T 1,703.32%๐Ÿ‡บ๐Ÿ‡ธ USA